|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000138398 |
Summary for PPIG |
Gene summary |
| Gene information | Ensembl ID | ENSG00000138398 | Gene symbol | PPIG |
| Gene name | peptidylprolyl isomerase G | |
| HGNC | 14650 | |
| Entrez ID | 9360 | |
| Gene type | protein_coding | |
| Synonyms | PPIG|CARS-Cyp|SRCyp|SCAF10 | |
| UniProtAcc | Q13427 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000138398 | PPIG | DB00172 | Proline | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PPIG |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for PPIG |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PPIG |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KICH | cg15993762 | chr2:169584189 | CGI:chr2:169584286-169584831 | promoter | 1.80e-01 | 3.51e-01 | 3.94e+00 | 8.26e-05 | 5.90e-04 | -1.71e-01 |
| DLBC | cg15993762 | chr2:169584189 | CGI:chr2:169584286-169584831 | promoter | 2.87e-01 | 6.65e-01 | 4.43e+00 | 9.51e-06 | 6.78e-05 | -3.78e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for PPIG |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PPIG |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | PPIG-010 | chr2_169628749_+ | 4.66e-01 | 3.02e-01 | 2.09e+00 | 3.71e-02 | 4.96e-02 | 1.64e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PPIG |
TFs related to PPIG.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
PPIG related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PPIG |
RBPs related to ES in PPIG.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | RALY | exon_skip_330906 | 6.86e+00 | 4.89e-03 | 7.36e+00 | 9.83e-01 | Female-biased |
| ACC | TIA1 | exon_skip_330906 | 6.89e+00 | 5.51e-03 | 7.37e+00 | 9.83e-01 | Female-biased |
| THYM | MATR3 | exon_skip_330910 | 7.02e+00 | 9.81e-01 | 6.65e+00 | 5.31e-03 | Male-biased |
| LUSC | ANKHD1 | exon_skip_330915 | 1.27e+01 | 5.48e-03 | 1.31e+01 | 9.94e-01 | Female-biased |
| LUSC | PABPC5 | exon_skip_330903 | 7.50e+00 | 9.86e-01 | 7.02e+00 | 3.90e-03 | Male-biased |
| DLBC | ANKHD1 | exon_skip_330915 | 1.38e+01 | 9.99e-01 | 1.31e+01 | 3.87e-04 | Male-biased |
| LUAD | ANKHD1 | exon_skip_330915 | 1.32e+01 | 9.98e-01 | 1.27e+01 | 1.37e-03 | Male-biased |
| ESCA | ANKHD1 | exon_skip_330915 | 1.25e+01 | 7.03e-03 | 1.30e+01 | 9.93e-01 | Female-biased |
| READ | ANKHD1 | exon_skip_330915 | 1.27e+01 | 9.78e-04 | 1.33e+01 | 9.99e-01 | Female-biased |
| READ | SRSF7 | exon_skip_330903 | 9.58e+00 | 3.30e-03 | 1.00e+01 | 9.95e-01 | Female-biased |
| THCA | ANKHD1 | exon_skip_330915 | 1.34e+01 | 9.99e-01 | 1.28e+01 | 2.95e-04 | Male-biased |
| PCPG | ANKHD1 | exon_skip_330915 | 1.30e+01 | 9.99e-01 | 1.25e+01 | 5.77e-04 | Male-biased |
| PCPG | PABPC5 | exon_skip_330903 | 6.99e+00 | 1.00e-03 | 7.52e+00 | 9.89e-01 | Female-biased |
| PCPG | SRSF7 | exon_skip_330903 | 9.65e+00 | 5.43e-03 | 1.00e+01 | 9.93e-01 | Female-biased |
| MESO | ANKHD1 | exon_skip_330915 | 1.24e+01 | 3.76e-03 | 1.28e+01 | 9.96e-01 | Female-biased |
| MESO | SRSF7 | exon_skip_330903 | 9.80e+00 | 4.15e-03 | 1.02e+01 | 9.94e-01 | Female-biased |
| LGG | ANKHD1 | exon_skip_330915 | 1.29e+01 | 9.98e-01 | 1.24e+01 | 1.49e-03 | Male-biased |
| KICH | SRSF7 | exon_skip_330903 | 9.56e+00 | 5.09e-03 | 9.94e+00 | 9.93e-01 | Female-biased |
| SARC | ANKHD1 | exon_skip_330915 | 1.33e+01 | 9.99e-01 | 1.26e+01 | 9.29e-04 | Male-biased |
PPIG related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs111676418 | chr2:173114849:G:A | - | 0.301596572023839 | 0.0129810474922103 | GBM | Female-baised eQTL |
| rs7561753 | chr2:170176637:C:G | - | 0.102996845896464 | 0.0369314367590094 | STAD | Female-baised eQTL |
| rs7591449 | chr2:173251401:T:C | - | 0.119847643807074 | 0.0373181370438472 | STAD | Female-baised eQTL |
| rs2601100 | chr2:168428536:A:G | - | 0.0546220447737973 | 0.00841212756294682 | LGG | Female-baised eQTL |
| rs2601099 | chr2:168428786:A:C | - | 0.0546220447737973 | 0.00841212756294682 | LGG | Female-baised eQTL |
| rs2601080 | chr2:168424133:G:A | - | -0.0545141718793316 | 0.00895179065743306 | LGG | Female-baised eQTL |
| rs2724157 | chr2:168427830:A:G | - | 0.0545141718793315 | 0.00895179065743306 | LGG | Female-baised eQTL |
| rs2123191 | chr2:168375009:T:A | - | -0.0613739888796077 | 0.0300860789725522 | LGG | Female-baised eQTL |
| rs2601079 | chr2:168424203:G:A | - | -0.0490249832906209 | 0.0307006433044485 | LGG | Female-baised eQTL |
| rs1597812 | chr2:168398071:A:T | - | -0.0512892736196834 | 0.0409355918796234 | LGG | Female-baised eQTL |
| rs4435417 | chr2:168398895:T:C | - | -0.0507638747306449 | 0.0471973952187577 | LGG | Female-baised eQTL |
| rs13005411 | chr2:170469185:T:G | - | 0.0719317223385665 | 0.00108345732169455 | LUAD | Female-baised eQTL |
| rs12992921 | chr2:170467989:T:C | - | 0.0698587605842468 | 0.00147497551610996 | LUAD | Female-baised eQTL |
| rs355814 | chr2:164853041:A:G | - | -0.0640210461610169 | 0.0129474001010507 | LUAD | Female-baised eQTL |
| rs10439299 | chr2:179218460:G:A | - | 0.0645558679256313 | 0.04625989310842 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10203430 | chr2:174128666:A:G | - | 0.0678242065457567 | 0.0408717746059818 | STAD | Male-baised eQTL |
| rs730289 | chr2:161058310:C:T | - | -0.0546237312301577 | 0.041628330107912 | LUAD | Male-baised eQTL |
| rs4668009 | chr2:168044567:A:C | - | -0.0784681797301558 | 2.71273046782736e-05 | COAD | Male-baised eQTL |
| rs2218915 | chr2:164420430:C:A | - | 0.086121429178986 | 0.000445985831294814 | COAD | Male-baised eQTL |
| rs13023450 | chr2:164531370:T:C | - | 0.101831198845985 | 0.000774417250643858 | COAD | Male-baised eQTL |
| rs10930685 | chr2:174731923:G:A | - | -0.0681100776414321 | 0.00287123933370131 | COAD | Male-baised eQTL |
| rs13035519 | chr2:164517450:A:C | - | 0.102929613803186 | 0.00441279046033481 | COAD | Male-baised eQTL |
| rs59724456 | chr2:164545291:T:C | - | 0.0866947647797503 | 0.00575040258038229 | COAD | Male-baised eQTL |
| rs7585997 | chr2:173005319:A:G | - | 0.0651146632100564 | 0.00659258703375541 | COAD | Male-baised eQTL |
| rs3754787 | chr2:168071269:A:G | - | -0.0622409917474742 | 0.00780391876630816 | COAD | Male-baised eQTL |
| rs12474905 | chr2:176086759:C:T | - | 0.0858095017385247 | 0.00823084744487276 | COAD | Male-baised eQTL |
| rs28756905 | chr2:164536742:A:G | - | 0.0840636661454355 | 0.00961493117556022 | COAD | Male-baised eQTL |
| rs4668002 | chr2:168036444:T:C | - | -0.0645407166570965 | 0.0097050548274481 | COAD | Male-baised eQTL |
| rs13014651 | chr2:164133069:A:C | - | 0.080398691236973 | 0.0104514934831436 | COAD | Male-baised eQTL |
| rs12620146 | chr2:164134167:G:T | - | 0.080398691236973 | 0.0104514934831436 | COAD | Male-baised eQTL |
| rs12619179 | chr2:164140280:A:C | - | 0.0807248677831636 | 0.012960857519849 | COAD | Male-baised eQTL |
| rs12612843 | chr2:164140281:C:T | - | 0.0807248677831636 | 0.012960857519849 | COAD | Male-baised eQTL |
| rs12612988 | chr2:164140829:C:T | - | 0.0807248677831636 | 0.012960857519849 | COAD | Male-baised eQTL |
| rs6747959 | chr2:171273543:T:C | - | 0.0835445399306102 | 0.0135631711651585 | COAD | Male-baised eQTL |
| rs74774050 | chr2:160509878:G:A | - | 0.102773421653449 | 0.0153783180321108 | COAD | Male-baised eQTL |
| rs11892933 | chr2:164150184:C:G | - | 0.0795736635309486 | 0.0157098416694975 | COAD | Male-baised eQTL |
| rs6731923 | chr2:164126534:A:T | - | 0.0769821628575255 | 0.0161013455229111 | COAD | Male-baised eQTL |
| rs6433027 | chr2:168007850:T:C | - | -0.058624760369906 | 0.0173179546549415 | COAD | Male-baised eQTL |
| rs6717944 | chr2:168025946:T:C | - | -0.0642092930454552 | 0.0182488092027825 | COAD | Male-baised eQTL |
| rs114773983 | chr2:160506812:C:T | - | 0.10072731377143 | 0.0191034047461366 | COAD | Male-baised eQTL |
| rs79875439 | chr2:160507131:C:T | - | 0.10072731377143 | 0.0191034047461366 | COAD | Male-baised eQTL |
| rs75051405 | chr2:160507670:C:T | - | 0.10072731377143 | 0.0191034047461366 | COAD | Male-baised eQTL |
| rs939643 | chr2:164531467:T:G | - | -0.054302260250812 | 0.0196149114185693 | COAD | Male-baised eQTL |
| rs67386813 | chr2:164142612:C:A | - | 0.0766089162404359 | 0.0198035080874224 | COAD | Male-baised eQTL |
| rs2044679 | chr2:168021788:A:T | - | -0.062104225577209 | 0.0208715966119952 | COAD | Male-baised eQTL |
| rs7559500 | chr2:168021972:C:T | - | -0.062104225577209 | 0.0208715966119952 | COAD | Male-baised eQTL |
| rs2044678 | chr2:168023418:C:T | - | -0.062104225577209 | 0.0208715966119952 | COAD | Male-baised eQTL |
| rs2044680 | chr2:168021692:T:A | - | -0.062005582027122 | 0.0210952251675114 | COAD | Male-baised eQTL |
| rs75476535 | chr2:160502002:C:T | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs74933630 | chr2:160502753:G:A | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs78270489 | chr2:160503275:C:T | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs75228928 | chr2:160503279:A:G | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs74838417 | chr2:160503765:C:T | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs199870632 | chr2:160503925:G:A | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs59501864 | chr2:160505344:T:A | - | 0.0994490501761668 | 0.0217982669338205 | COAD | Male-baised eQTL |
| rs35824749 | chr2:164131240:A:G | - | 0.0731272725964112 | 0.0222766860177482 | COAD | Male-baised eQTL |
| rs16854567 | chr2:168019608:G:A | - | -0.0572619635982075 | 0.023290068009153 | COAD | Male-baised eQTL |
| rs12464825 | chr2:164538070:T:G | - | -0.0536134673564256 | 0.02513536340859 | COAD | Male-baised eQTL |
| rs728700 | chr2:163721059:G:A | - | 0.095915863377795 | 0.0255600900950397 | COAD | Male-baised eQTL |
| rs10497243 | chr2:163722415:C:T | - | 0.095915863377795 | 0.0255600900950397 | COAD | Male-baised eQTL |
| rs114736548 | chr2:163722879:A:T | - | 0.095915863377795 | 0.0255600900950397 | COAD | Male-baised eQTL |
| rs34825475 | chr2:164138983:G:C | - | 0.073769662984307 | 0.0255931027670266 | COAD | Male-baised eQTL |
| rs12479049 | chr2:163714235:C:A | - | 0.0957701786833875 | 0.0258386701358916 | COAD | Male-baised eQTL |
| rs80163246 | chr2:163717834:T:C | - | 0.0957701786833875 | 0.0258386701358916 | COAD | Male-baised eQTL |
| rs74998824 | chr2:163729086:A:C | - | 0.0957701786833875 | 0.0258386701358916 | COAD | Male-baised eQTL |
| rs74933019 | chr2:163730500:G:A | - | 0.0956308609151715 | 0.0263406974574041 | COAD | Male-baised eQTL |
| rs1460665 | chr2:163730937:A:G | - | 0.0956308609151715 | 0.0263406974574041 | COAD | Male-baised eQTL |
| rs1375309 | chr2:168014129:A:G | - | -0.0563193914339657 | 0.0287347496752065 | COAD | Male-baised eQTL |
| rs12233099 | chr2:160435457:C:T | - | 0.0843792045841954 | 0.0287892898394209 | COAD | Male-baised eQTL |
| rs655510 | chr2:164513551:A:C | - | -0.0519208350801846 | 0.0291446070269951 | COAD | Male-baised eQTL |
| rs55900907 | chr2:168019494:G:A | - | -0.0564067842636403 | 0.0294575138283348 | COAD | Male-baised eQTL |
| rs16845343 | chr2:160941472:A:T | - | 0.071381012861471 | 0.0303847005309814 | COAD | Male-baised eQTL |
| rs12993321 | chr2:164120815:T:C | - | 0.0709875205576283 | 0.0315321333673711 | COAD | Male-baised eQTL |
| rs36022645 | chr2:164121186:C:T | - | 0.0709875205576283 | 0.0315321333673711 | COAD | Male-baised eQTL |
| rs73008312 | chr2:160426448:C:A | - | 0.0835045097643555 | 0.0316533468421558 | COAD | Male-baised eQTL |
| rs6725287 | chr2:160438788:C:T | - | 0.0835045097643555 | 0.0316533468421558 | COAD | Male-baised eQTL |
| rs6725626 | chr2:160438916:G:A | - | 0.0835045097643555 | 0.0316533468421558 | COAD | Male-baised eQTL |
| rs1915137 | chr2:176456501:T:C | - | 0.0533026505811532 | 0.0337579176936632 | COAD | Male-baised eQTL |
| rs78441029 | chr2:160507368:T:C | - | 0.0944260821657789 | 0.0341929522963146 | COAD | Male-baised eQTL |
| rs6710953 | chr2:173495281:A:C | - | 0.0563416820747811 | 0.0347854915719809 | COAD | Male-baised eQTL |
| rs751608 | chr2:163704798:G:T | - | 0.0976770240909339 | 0.0355375587009054 | COAD | Male-baised eQTL |
| rs75057174 | chr2:163709124:C:T | - | 0.0961120273624044 | 0.0382209718535838 | COAD | Male-baised eQTL |
| rs3754753 | chr2:173000556:T:C | - | -0.0538914978520731 | 0.0410776297244813 | COAD | Male-baised eQTL |
| rs4667551 | chr2:168048112:T:C | - | -0.0540349395588506 | 0.0442450468568525 | COAD | Male-baised eQTL |
| rs2121482 | chr2:173012044:G:A | - | 0.0549325072267714 | 0.0445772194772309 | COAD | Male-baised eQTL |
| rs4972581 | chr2:173493136:A:G | - | 0.0549368059908377 | 0.0446865965222237 | COAD | Male-baised eQTL |
| rs34552881 | chr2:165447464:C:T | - | 0.0932508064573801 | 0.04618238523637 | COAD | Male-baised eQTL |
| rs4435420 | chr2:171609166:G:A | - | 0.0520034968781171 | 0.0462818340779805 | COAD | Male-baised eQTL |
| rs10497219 | chr2:160934131:C:T | - | 0.0702809048653732 | 0.0476359522916858 | COAD | Male-baised eQTL |
| rs12469383 | chr2:163735859:C:T | - | 0.0913228006179055 | 0.0486856707593929 | COAD | Male-baised eQTL |
| rs12469467 | chr2:163735905:G:C | - | 0.0913228006179055 | 0.0486856707593929 | COAD | Male-baised eQTL |
| rs6756551 | chr2:173492657:A:G | - | 0.0546542970365146 | 0.0487182018417756 | COAD | Male-baised eQTL |
| rs4972580 | chr2:173492965:C:G | - | 0.0546170781299251 | 0.0489725811387976 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PPIG |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |